	NECKCHECK project: development and validation of a digital checklist for radiologic assessment of oral cavity squamous cell carcinoma. Clin Oral Investig Ferrero-Coloma SM, Quesada JA, Izquierdo-Luzón J, Ferrero-Coloma C, Sancho-Mestre M, Garcia-Garrigós E, Pereira-Expósito A, Gil-Guillen V. PMID: 42168667 [PubMed - indexed for MEDLINE]
	Nivolumab and ipilimumab combination therapy for melanoma efficacy, safety and clinical integration in metastatic and adjuvant settings. Discov Oncol Afuh R, Ashinze P, Banerjee S, Egbunu E, Olaniyan MO, Ayo-Ige AB, Soyinka EK, Atere AO, Igwe S, Oladipupo YM, Obaoye A, Nasiru Y, Aboderin C, Olowookere S. PMID: 42168665 [PubMed - as supplied by publisher]
	Use of circulating tumour DNA to prospectively guide a switch from targeted to immune therapy in BRAF mutant advanced melanoma: the randomised phase II CAcTUS trial. Nat Commun Lee RJ, Rothwell DG, Smith N, Chow S, Delgado-SanMartin J, Mistry H, Sylvestre Y, Chiang SC, Clarke H, Gremel G, Gupta A, Hockenhull K, Kelso N, Kochhar R, Mullan D, Plummer R, Serra P, Shaw H, Summersgill H, Turajlic S, Mouliere F, Marais R, Dive C, Lorigan P. PMID: 42168180 [PubMed - as supplied by publisher]
	Nanomedicine to enhance melanoma radiotherapy: Mechanisms and translational prospects. J Pharmacol Exp Ther Hsu CY, Rizaev J, AlAbdulhadi SAS, Abbas Al-Khafaji ZK, Gupta PK, Samikan KR, Sahoo S, Bainsal N. PMID: 42167125 [PubMed - as supplied by publisher]
	Skin Cancer: Management of Cutaneous Melanoma. FP Essent Nelson M MD, FAAFP, Hamel RK MD, Nash J MD. PMID: 42166765 [PubMed - indexed for MEDLINE]
	Skin Cancer: Management of Actinic Keratoses and Keratinocyte Carcinomas. FP Essent Nelson M MD, FAAFP, Nash J MD, Hamel RK MD. PMID: 42166764 [PubMed - indexed for MEDLINE]
	Skin Cancer: Diagnosis. FP Essent Nelson M MD, FAAFP, Hamel RK MD, Nash J MD. PMID: 42166763 [PubMed - indexed for MEDLINE]
	Skin Cancer: Screening and Prevention. FP Essent Nelson M MD, FAAFP, Hamel RK MD, Nash J MD. PMID: 42166762 [PubMed - indexed for MEDLINE]
	Correction to: A national cohort study of melanoma BRAF status, testing patterns, patient and tumour characteristics, treatment and survival in England from 2016 to 2021. Br J Dermatol PMID: 42166717 [PubMed - as supplied by publisher]
	Pregnancy and risk of melanoma: a matched retrospective cohort study. Melanoma Res Block BR, Mehta J, Powers CM, Ungar J, Farabi Atak SB, Gulati N. PMID: 42166631 [PubMed - as supplied by publisher]
	Ultrasound imaging features of cervical lymph nodes with melanoma metastasis compared with benign cervical nodes. Melanoma Res Alizada S, Al Qudah H, Vu T, Stewart J, Shah K, Debnam JM, Sahu S, Salim HA, Msherghi A, Maniakas A, Zafereo ME, Goepfert RP, Wintermark M, Ahmed S. PMID: 42166628 [PubMed - as supplied by publisher]
	Clinical and economic burden of recurrence among older patients with locoregionally advanced head and neck squamous cell carcinoma in the United States. J Manag Care Spec Pharm Zheng D, Zhang S, Bidadi B, Lerman N, Song Y, Tang Y, Song R, Li J, Zhu A, Signorovitch J, Merchant S, Hanna GJ. PMID: 42166302 [PubMed - indexed for MEDLINE]
	Malignant Melanoma Misdiagnosis in the Diabetic Foot. What Can We Learn From the Published Literature? J Foot Ankle Res Bristow IR, Reynolds ML, Young M. PMID: 42165691 [PubMed - indexed for MEDLINE]
	Association of XPD Gene Polymorphisms with Cutaneous Melanoma Risk: A Meta-Analysis and Trial Sequence Evaluation. Cancer Invest Farnoush N, Rahmani A, Khosravi-Mashizi M, Shiri A, Dastgheib SA, Barahman M, Shirinzadeh-Dastgiri A, Vakili-Ojarood M, Naseri A, Asadian F, Aghasipour M, Aghili K, Neamatzadeh H. PMID: 42165380 [PubMed - as supplied by publisher]
	Camrelizumab Plus Famitinib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Study. Cancer Med Xu B, Zhu G, Lu J, Zhang X, Chen X, Liu Q, Qu S, Fan J, Liu T. PMID: 42165088 [PubMed - indexed for MEDLINE]
	European Expert Consensus on Essential Variables for Teledermatological Assessment of Skin Tumours. Acta Derm Venereol Detlefsen A, Vestergaard T, Ternov NK, Konge L, Ingvar Å, Nielsen K, Assersen KB. PMID: 42163824 [PubMed - indexed for MEDLINE]
	Tebentafusp (IMCgp100), a first in class immune-mobilizing monoclonal T-cell receptors against cancer (ImmTAC) for HLA-A*02:01 positive uveal melanoma: Product review. Hum Vaccin Immunother Cohen JE, Mehmi I, Avner M, Moyers J, Hamid O. PMID: 42163062 [PubMed - indexed for MEDLINE]
	Five-Year Survival with Tebentafusp in Metastatic Uveal Melanoma. Ann Oncol Piperno-Neumann S, Rutkowski P, Hassel JC, Butler MO, Schlaak M, Sullivan RJ, Dummer R, Kirkwood JM, Sacco JJ, Shoushtari AN, Piulats JM, Salama AKS, Orloff MM, Joshua AM, Ochsenreither S, Gastaud L, Curti BD, Demidov LV, Milhem MM, Chmielowski B, Kendra KL, Ascierto PA, Bernicker EH, Carvajal RD, Collins L, Lockwood S, Patel JM, Hamid OA, Baurain JF, Nathan PD. PMID: 42162665 [PubMed - as supplied by publisher]
	Oncologic, functional, and economic outcomes of transoral robotic surgery for HPV-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of pathology and treatment strategies. J Robot Surg Hajihosseni H, Hajitaghizadeh R, Sharifi HR, Lin D. PMID: 42162526 [PubMed - indexed for MEDLINE]
	HLA Class II Alleles DRB111:01 and DQB103:01 Unmask Immunogenetic Susceptibility to Anti-Nivolumab Antibodies in Combination with Ipilimumab. AAPS J Rajendran S, Gutierrez AH, Chien MS, Tang T, Gokemeijer J, Forman D, De Groot AS, Jawa V, Hamuro L. PMID: 42162441 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 142869

Page 1 of 7144



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy